Synopsys (SNPS) Shares Outstanding (Weighted Average) (2009 - 2026)

Synopsys has reported Shares Outstanding (Weighted Average) for 18 years, with the latest figure at $189.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 22.79% year-over-year to $189.6 million; the trailing twelve-month figure through Jan 2026 stood at $189.6 million (up 22.79% YoY), and the FY2025 full-year result was $163.9 million, up 7.06% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $189.6 million, up from $163.9 million in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $189.6 million in Q1 2026, with the low at $152.0 million in Q3 2023.
• Historically, Shares Outstanding (Weighted Average) has averaged $156.0 million across 5 years, with a median of $153.1 million in 2022.
• Annual changes were most pronounced in 2023 — Shares Outstanding (Weighted Average) retreated 0.69% — and 2026, when it climbed 22.79%.
• Synopsys' Shares Outstanding (Weighted Average) stood at $153.0 million in 2022, then declined by 0.56% to $152.1 million in 2023, then climbed by 0.65% to $153.1 million in 2024, then advanced by 7.06% to $163.9 million in 2025, then increased by 15.64% to $189.6 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $189.6 million (Q1 2026), $163.9 million (Q4 2025), and $156.5 million (Q3 2025), per Business Quant data.